applications to the fiscal year 2019 (fy19) defense medical research and development program (dmrdp) joint program committee 8/clinical and rehabilitative medicine research program (jpc-8/crmrp), restoring warfighters with neuromusculoskeletal injuries research award (restore) are being solicited for the defense health agency (dha) j9, research and development directorate, by the u.s. army medical research acquisition activity (usamraa) using delegated authority provided by united states code, title 10, section 2358 (10 usc 2358). as directed by the office of the assistant secretary of defense for health affairs (oasd[ha]), the dha manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the congressionally directed medical research programs (cdmrp) provides dmrdp execution management support for dhp core research program areas, including jpc-8/crmrp. this program announcement/ funding opportunity and subsequent awards will be managed and executed by cdmrp with strategic oversight from jpc-8/crmrp.

the fy19 program announcement and general application instructions for the following award mechanism are posted on the grants.gov website.

https://cdmrp.army.mil/funding/pa/fy19-jpc8-restore.pdf

restoring warfighters with neuromusculoskeletal injuries research award (restore) – preproposal due september 3, 2019

for all research levels:  investigators at or above the level of assistance professor (or equivalent).

• ·         supports research in the areas of optimal management, treatment, and restoration following service-related neuromusculoskeletal injury, including acute combat/non-combat injury, repetitive overuse injury, limb loss, and limb trauma.
• ·         proposed projects will accelerate progress toward returning warfighters to combat readiness following neuromusculoskeletal injury.
• ·         collaboration among academia, industry, the dod, and the department of veterans affairs is encouraged.
• ·         applications submitted to the restore must address one or more of the focus areas.
• ·         fundamental basic research is not allowed.
• ·         preproposal submission is required; application submission is by invitation only.

the restore offers three research levels:

research level 1:

• ·         maximum funding of $500,000 for total costs (direct costs plus indirect costs).
• ·         maximum period of performance is 3 years.

research level 2:

• ·         maximum funding of $1,500,000 for total costs (direct costs plus indirect costs).
• ·         maximum period of period 4 years.

research level 3:

• ·         maximum funding of $3,000,000 for total costs (direct costs plus indirect costs).
• ·         maximum period of performance is 4 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the phtbirp or other cdmrp-administered and supported programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507 
help@ebrap.org

cihr’s health research training strategy aims to equip research trainees so that they emerge from their training as scientific, professional, or organizational leaders within and beyond the health research enterprise. generating research leaders of tomorrow is a key objective for cihr.

fellowships provide support for highly qualified applicants in all areas of health research at the post-phd degree or post-health professional degree stages to add to their experience by engaging in health research either in canada or abroad.

the funding opportunity catalyst grant: hiv/aids community-based research is expected to:

• support partnerships between communities affected by hiv and other stbbi in canada and researchers to facilitate the conduct of cbr; and/or
• develop future applications for more comprehensive cbr grants in the area of hiv and other stbbi in canada.

examples of activities that might be conducted under this request for applications are (but are not restricted to):

• facilitation of dialogue between communities and researchers in order to establish research partnerships;
• workshops to design a research project and/or develop a proposal for a future cbr operating grant;
• planning and execution of pilot projects or feasibility studies to generate preliminary data, proof of concept; and/or
• development and/or validation of new interventions, tools, methodologies, protocols, theoretical models or frameworks.

for examples, applicants can visit cihr's funding decisions web site to search for projects previously funded under a cihr hiv/aids cbr catalyst grant.

the objective of this funding opportunity is to catalyze and support research efforts of canadian researchers to use the available clsa data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

the project grant program is expected to:

• support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• promote relevant collaborations across disciplines, professions, and sectors; and
• contribute to the creation and use of health-related knowledge.

the project grant program is expected to:

• support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• promote relevant collaborations across disciplines, professions, and sectors; and
• contribute to the creation and use of health-related knowledge.

5g and iot infrastructure and new applications are expected to generate massive amounts of data, thereby driving changes to network architecture. data processing and content distribution will be forced closer to the network edge, driving the need for much more efficient and programmable edge compute infrastructure. traditionally, such edge compute infrastructure needs have been met with field programmable gate arrays (fpgas) providing a reprogrammable protocol handling layer (at phys or nics), and generic cpus (possibly augmented with gpus) interconnected through a largely static network switching fabric. the objective of this project is to investigate approaches and develop a software tool kit for managing and programming a fabric of interconnected fpgas. the fpga fabric (i.e. multiple fpgas interconnected to appear as a single large virtual fpga) is intended to absorb functions that are currently spread across multiple elements: protocol adapters, switching asics, networking functions, data processing cpu/gpu functions, etc. the project is expected todeliver a set of algorithms, techniques and tools for adaptive and optimized sizing, placement and chaining of required functions inside the fpga fabric.

the objective of this research challenge is to develop and verify artificial intelligence/machine learning (ai/ml) driven approaches for automated design, planning and operations of ‘full stack’ 5g era systems employing the principles of self-organization and self-optimization.

the fy19 defense appropriation provides $125 million (m) to the department of defense psychological health and traumatic brain injury research program (phtbirp) to support specific defense health agency (dha) j9 research and development directorate program areas, including joint program committee-5/military operational medicine research program (jpc-5/momrp).  as directed by the office of the assistant secretary of defense for health affairs, the dha j9 research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcement/funding opportunity is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and materiel command (usamrmc).

the fy19 phtbirp program announcement and general application instructions for the following award mechanism are posted on the grants.gov website.

https://cdmrp.army.mil/funding/phtbi

prevention research to reduce sexual assault and/or understand adjustment disorders (psaad) – letter of intent due september 19, 2019

investigators at all academic levels are eligible to be names as a principal investigator on the application.

• the psaad iifra is intended to support research focused on (1) development or adaptation of prevention efforts to reduce the occurrence of sexual assault and/or harassment and/or (2) understanding the diagnosis, assessment, and screening of adjustment disorders as a consequence of sexual assault and/or stressors that precipitate adjustment disorders.
• all applications must address at least one of the psaad iifra focus areas and be of clear scientific merit with direct relevance to military and public health.
• research involving human subjects is permitted; however, this award may not be used to conduct clinical trials.
• preclinical research using animals is not permitted.
• this funding opportunity is not focused on veterans.
• submission of a letter of intent is required.
• maximum funding of $750k for direct costs (includes direct and indirect costs).
• maximum period of performance is 3 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrmc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the phtbirp or other cdmrp-administered and supported programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk

301-682-5507 
help@ebrap.org

the genomic applications partnership program (gapp) funds downstream research and development (r&d) projects that address real world opportunities and challenges defined by “receptor” organizations such as industry, government, or not-for-profit entities. these organizations should be committed to commercializing or implementing the outcomes of the project. projects are led by the receptor organization (canadian or international) but are active collaborations with a canadian academic researcher. these projects are co-funded by receptors and other stakeholders and must have the potential to generate significant social and/or economic benefits for canada. the gapp aims to:

• accelerate the application of canadian genomics-derived solutions from academia to real-world opportunities and challenges defined by industry, not-for-profit and public-sector receptors.
• channel canada’s genomics capacity into sustainable innovations that benefit canadians.
• enhance the value of canadian genomics technologies by de-risking and incentivizing follow-on investment from industry and other partners.
• foster mutually beneficial collaboration and knowledge exchange between canadian academia and technology receptors.